Related references
Note: Only part of the references are listed.Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Dominic Schmid et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
Karolina Minta et al.
FLUIDS AND BARRIERS OF THE CNS (2021)
Tumor DNR Mutations From Intraparenchymal Brain Metastases Are Detectable in CSF
Stephanie Kim Cheok et al.
JCO PRECISION ONCOLOGY (2021)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid
Ihor Batruch et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma
Zhenyu Pan et al.
FRONTIERS IN ONCOLOGY (2020)
Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
Joakim Bergman et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis
Kyue-Yim Lee et al.
CANCERS (2020)
Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications
Ilijana Begcevic et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
Ilijana Begcevic et al.
JOURNAL OF PROTEOMICS (2018)
Complement and the Regulation of T Cell Responses
Erin E. West et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors
Leomar Y. Ballester et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
Byong Chul Yoo et al.
ONCOTARGET (2017)
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis
Adrienne Boire et al.
CELL (2017)
Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
Sameer Agnihotri et al.
NEURO-ONCOLOGY (2016)
Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors
Youngbo Shim et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Low-mass-ion discriminant equation: A new concept for colorectal cancer screening
Jun Hwa Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset
Davide Chiasserini et al.
JOURNAL OF PROTEOMICS (2014)
Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study
Ho-Shin Gwak et al.
ONCOLOGIST (2014)
Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence
Stephen B. Hladky et al.
FLUIDS AND BARRIERS OF THE CNS (2014)
Neuroprotein Dynamics in the Cerebrospinal Fluid: Intraindividual Concomitant Ventricular and Lumbar Measurements
Sebastian Brandner et al.
EUROPEAN NEUROLOGY (2013)
GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients
Satoshi Nakamizo et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Leptomeningeal Metastasis from Non-small Cell Lung Cancer Survival and the Impact of Whole Brain Radiotherapy
Patrick G. Morris et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Identification and proteomic profiling of exosomes in human cerebrospinal fluid
Jonathan M. Street et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
Jin Hyun Park et al.
LUNG CANCER (2012)
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
Nadiya M. Teplyuk et al.
NEURO-ONCOLOGY (2012)
Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells
David A. Foster
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Leptomeningeal Carcinomatosis Prognostic Implications of Clinical and Cerebrospinal Fluid Features
Jordi Bruna et al.
CANCER (2009)
Leptomeningeal metastases from solid malignancy: a review
S Taillibert et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer
LJ Dekker et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Share Paper
